Similarly, platelets genetically engineered to overexpress PD-L1 accumulate in pancreas and inhibit the activity of islet-specific autoreactive T cells, reversing new-onset T1D [45]. The gene discussed is CD274; the disease is type 1 diabetes mellitus.